Navigation Links
FDA Reports New Risks Posed by Anemia Drugs
Date:1/3/2008

ells. The drugs are manufactured by Amgen, of Thousand Oaks, Calif. Procrit is marketed and distributed by Ortho Biotech LP of Bridgewater, N.J., a subsidiary of Johnson & Johnson.

For cancer patients, November's revised warnings emphasized that the drugs can cause tumor growth and reduce survival among patients with advanced breast, head and neck, lymphoid and non-small cell lung tumors. This is especially true when the dose is designed to produce a hemoglobin level of 12 grams per deciliter of blood or more.

For hemoglobin levels less than 12 grams per deciliter, the label says there's no evidence to determine if the drugs cause any of these problems, the FDA said.

The revised label also made it clear that ESAs should be used in cancer patients only when their anemia is caused by chemotherapy and not from other causes. Also, ESAs should be stopped when the patient's chemotherapy has ended, the FDA said.

The revised label also said there's no evidence that ESAs improve symptoms of anemia, quality of life, fatigue, or patient well-being in cancer patients or patients with HIV taking the drug AZT.

More information

For more information on ESAs, visit the U.S. Food and Drug Administration.



SOURCES: Jan. 3, 2008, news release, U.S. Food and Drug Administration; Nov. 8, 2007, teleconference with Richard Pazdur, M.D., director, Office of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration; John Jenkins, M.D., director, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Lincare Holdings Inc. Reports Intention to File Shelf Registration Statement
2. UCI Medical Affiliates, Inc. Reports Fiscal Year End Results for September 30, 2007
3. The Ensign Group, Inc. Reports Third Quarter 2007 Earnings
4. HealthPartners Reports 2007 Most Cost Effective Programs Reduce Expenses by $74 Million
5. Par Pharmaceutical Reports Third-Quarter 2007 Results
6. Briggs & Riley Reports That More Travelers Focus on Health and Sanitation This Holiday Season
7. Recent Reports Underscore the Importance of Testing Supplements for Athletic Banned Substances
8. Intensive care quality of sleep improved by new drug, reports study
9. Biodel Inc. Reports Fourth Quarter and Fiscal Year 2007 Financial Results
10. IBM reports milestone in silicon nanophotonics
11. Telik Reports Positive Results From Phase 1 Dose-Escalation Study of TELINTRA Tablets in Myelodysplastic Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Reports New Risks Posed by Anemia Drugs
(Date:9/2/2014)... The Jerry Segal Classic to benefit ... 19 at The ACE Club and Green Valley Country ... years, the Classic, organized by the Friends of Jerry ... and services designed to support patients and their families ... “The Segal Classic is a labor of love, my ...
(Date:9/2/2014)... Port Washington, New York (PRWEB) September 02, 2014 ... Waichman LLP announces that Class Counsel has ... and for service awards in the class action ... to Parker Waichman LLP, the Court-Appointed Class Counsel ... Cabraser Heimann & Bernstein, LLP; Audet & Partners, ...
(Date:9/2/2014)... 2014 Lseat.com is one of the most ... its products are user-friendly items; no professional installation is required. ... they can slip right over the cars’ seats. That can ... website is filled with various kinds of practical covers. ... of Jeep leather seat covers . Also, the company ...
(Date:9/2/2014)... California (PRWEB) September 02, 2014 The ... reach USD 8,918.8 million by 2020, growing at an ... to a new study by Grand View Research, Inc. ... and plague modification devices are used for treating peripheral ... formation of atherosclerotic plaques in arteries. These devices are ...
(Date:9/2/2014)... 2014 Eric Jimenez and Leah Ashley ... a revolutionary makeup application device. Designed to improve and ... in the palm of women’s hands to help them ... Color Me’s success lies in its patented technology. With ... of 15,000 pulses per minute, the device applies foundation ...
Breaking Medicine News(10 mins):Health News:The 25th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:A Proposed Order Has Been Submitted in A Class Action Law Suit Brought Over Flushmate Toilets, Parker Waichman Announces 2Health News:A Proposed Order Has Been Submitted in A Class Action Law Suit Brought Over Flushmate Toilets, Parker Waichman Announces 3Health News:High Quality 1997-2006 JEEP Wrangler TJ Leather Seat Covers From Popular Supplier Lseat.com 2Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 2Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 3Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 4Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 5Health News:Color Me Launches With Ulta Beauty Revolutionary Makeup Application Device Gets Women Flawless in a Flash 2Health News:Color Me Launches With Ulta Beauty Revolutionary Makeup Application Device Gets Women Flawless in a Flash 3
... a story that continues,to captivate millions of Americans ... transplants, golfer and double heart transplant,recipient Erik Compton ... as he pursues his quest to qualify for ... in Brooksville, Florida., (Photo: http://www.newscom.com/cgi-bin/prnh/20081112/CLW035 ...
... Quantum Group,Inc. (Amex: QGP ) (http://www.QuantumMD.com ... of a scheduled presentation to be,delivered at Paulson ... J. Guillama later this morning, announced today that,it ... 3,650 using the community,health systems (CHS) established by ...
... Infection, LANSING, Mich., Nov. 12 For those ... and flu season, there,s yet another reason to,choose cherries, ... typical flu vaccine, a new study suggests quercetin, a ... in a,variety of fruits and vegetables, including tart cherries, ...
... an early,stage company developing an implantable neuromodulation system ... has closed a licensing,and financing deal, led by ... Existing investor, Greatbatch, Inc. (NYSE: GB ), ... that will provide between,$11 million and $13.5 million ...
... High-Quality Emergency,Healthcare to Rural Areas, NEW YORK, ... announced that it has been selected by Ameya,Preserve ... supplier for each,of the 300 new homes built ... the first of its kind in the United ...
... is facing a medical liability crisis which has,resulted in ... Pacific Research Institute (a not for profit, nonpartisan,organization), was ... total,cost of tort litigation in our country. They have ... due to lawsuit abuse totals $589,billion each year., ...
Cached Medicine News:Health News:Millions Follow Erik Compton's Quest to Win a PGA TOUR Card and Build Awareness for Organ Donation 2Health News:Millions Follow Erik Compton's Quest to Win a PGA TOUR Card and Build Awareness for Organ Donation 3Health News:The Quantum Group Announces Continued Growth of Patient Base and Preliminary Revenue Guidance 2Health News:The Quantum Group Announces Continued Growth of Patient Base and Preliminary Revenue Guidance 3Health News:The Quantum Group Announces Continued Growth of Patient Base and Preliminary Revenue Guidance 4Health News:New Research Shows Specific Antioxidant, Found in Cherries, May Boost the Body's Defenses Against the Flu 2Health News:Intelect Medical Closes $11 Million in Funding from Boston Scientific and Greatbatch for Stroke and TBI Recovery Clinical Trials 2Health News:Intelect Medical Closes $11 Million in Funding from Boston Scientific and Greatbatch for Stroke and TBI Recovery Clinical Trials 3Health News:Intelect Medical Closes $11 Million in Funding from Boston Scientific and Greatbatch for Stroke and TBI Recovery Clinical Trials 4Health News:SwiftMD to Provide Telemedicine Services to New Montana Development 2Health News:SwiftMD to Provide Telemedicine Services to New Montana Development 3Health News:How Texas Cured Its Doctor Shortage and Became a Model for Healthcare Reform 2Health News:How Texas Cured Its Doctor Shortage and Became a Model for Healthcare Reform 3
(Date:9/2/2014)... DIEGO , Sept. 2, 2014  Volcano ... company focused on improving patient and economic outcomes ... innovative minimally invasive coronary and peripheral visualization, physiology ... be participating in the Morgan Stanley Healthcare conference ... by Scott Huennekens , president and chief ...
(Date:9/2/2014)... Sept. 2, 2014  BioSpecifics Technologies Corp. (NASDAQ: ... products marketed as XIAFLEX ® in the U.S. and ... President, Tom Wegman , will present at the following ... Rodman & Renshaw 16 th Annual ... Tuesday, September 9, 2014 at 9:10 a.m. EDT ...
(Date:9/2/2014)... , September 2, 2014 ... NASDAQ: EMITF ) announced today following the ... Technologies Ltd. ("Elbit Medical") (TASE: EMTC-M), a subsidiary of ... a fully diluted basis, announced that on September 1, ... approximately 30.8% of the voting power ("Gamida Cell") and ...
Breaking Medicine Technology:BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences 2Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company 2Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company 3
... Phase IIa Trial Increase in Dendritic, ... BASKING RIDGE, N.J., Oct. 10 VioQuest,Pharmaceuticals ... company focused on acquiring, developing and,commercializing targeted ... enrollment in its Phase I open-label dose ...
... New Phase 3 Plan Could Expedite Clinical Development Pathway, ... (Nasdaq: ANSV ) today announced that it will ... Adlea(TM) -- one of which has already,been planned in ... in,bunionectomy surgeries -- for a broad product label of ...
Cached Medicine Technology:VioQuest Pharmaceuticals Completes Enrollment of Phase I Trial of Lenocta(TM) 2VioQuest Pharmaceuticals Completes Enrollment of Phase I Trial of Lenocta(TM) 3VioQuest Pharmaceuticals Completes Enrollment of Phase I Trial of Lenocta(TM) 4Anesiva Defines Regulatory Pathway for Adlea with FDA 2Anesiva Defines Regulatory Pathway for Adlea with FDA 3Anesiva Defines Regulatory Pathway for Adlea with FDA 4Anesiva Defines Regulatory Pathway for Adlea with FDA 5
Multi-frequency, HST, linear transducer with a longer (60mm) footprint. Available with puncture adapter and water path. This transducer incorporates ALOKAs exclusive Hemispheric Sound Technology and ...
Multi-frequency, Super High Density, linear transducer with a longer (60mm) footprint. Available with puncture adapter and water path....
... high frequency (13Mhz) ... and superficial imaging. ... Hemispheric Sound Technology ... This multi-frequency transducer ...
This versatile convex array abdominal transducer is multi-frequency, offering 5 levels of fundamental frequencies in addition to 4 settings of Harmonic frequencies. This transducer provides superb im...
Medicine Products: